CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare’s Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test

Posted on by

LOS ANGELES, Jan. 21, 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its expertise in the areas of in-vitro diagnostics (IVDs) and medical devices, proudly announced today that the U.S. Food and Drug Administration (FDA) granted 510(k)…